{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:18:43Z","timestamp":1793121523884,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600458"],"award-info":[{"award-number":["81600458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070585"],"award-info":[{"award-number":["82070585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370574"],"award-info":[{"award-number":["82370574"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400604"],"award-info":[{"award-number":["82400604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007046","name":"Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0507500"],"award-info":[{"award-number":["2018YFA0507500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ymthe.2025.01.046","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T19:11:38Z","timestamp":1738609898000},"page":"1825-1841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The deubiquitinase USP28 maintains the expression of PPAR\u03b3 and its inactivation protects mice from diet-induced MASH and hepatocarcinoma"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4602-5046","authenticated-orcid":false,"given":"Changzhou","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianrong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6172-1253","authenticated-orcid":false,"given":"Chengfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.01.046_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2024.04.009","article-title":"Targeting EFHD2 Inhibits Interferon-\u03b3 Signaling and Ameliorates Non-Alcoholic Steatohepatitis","volume":"81","author":"Fu","year":"2024","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/12781","article-title":"Genetic manipulations of PPARs: effects on obesity and metabolic disease","volume":"2007","author":"Barak","year":"2007","journal-title":"PPAR Res."},{"key":"10.1016\/j.ymthe.2025.01.046_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11892-021-01385-5","article-title":"PPAR\u03b3 and Diabetes: Beyond the Genome and Towards Personalized Medicine","volume":"21","author":"Cataldi","year":"2021","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.ymthe.2025.01.046_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fendo.2017.00102","article-title":"The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research","volume":"8","author":"Wafer","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","author":"Larter","year":"2008","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12020-014-0384-x","article-title":"Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients","volume":"48","author":"Pan","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ymthe.2025.01.046_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib10","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1172\/JCI200317223","article-title":"Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes","volume":"111","author":"Matsusue","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.046_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.cmet.2008.03.003","article-title":"Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27","volume":"7","author":"Matsusue","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2025.01.046_bib12","doi-asserted-by":"crossref","first-page":"37603","DOI":"10.1074\/jbc.M604709200","article-title":"Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis","volume":"281","author":"Zhang","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib13","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1096\/fj.10-173716","article-title":"Role for PPAR\u03b3 in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts","volume":"25","author":"Mor\u00e1n-Salvador","year":"2011","journal-title":"FASEB J. : official Publ. Fed. Am. Societies Exp. Biol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9735083","article-title":"Loss of Hepatocyte-Specific PPAR\u03b3 Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient Diet","volume":"2020","author":"Cordoba-Chacon","year":"2020","journal-title":"PPAR Res."},{"key":"10.1016\/j.ymthe.2025.01.046_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev-biochem-062917-011931","article-title":"Structure and Function of the 26S Proteasome","volume":"87","author":"Bard","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","article-title":"Recognition and processing of ubiquitin-protein conjugates by the proteasome","volume":"78","author":"Finley","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib17","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1681\/ASN.2006010083","article-title":"Protein degradation by the ubiquitin-proteasome pathway in normal and disease states","volume":"17","author":"Lecker","year":"2006","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib18","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2010.11.012","article-title":"Ubiquitin: same molecule, different degradation pathways","volume":"143","author":"Clague","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.01.046_bib19","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1007\/s00018-016-2255-5","article-title":"The recognition of ubiquitinated proteins by the proteasome","volume":"73","author":"Grice","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.01.046_bib20","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","article-title":"Deubiquitylases from genes to organism","volume":"93","author":"Clague","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2025.01.046_bib21","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","article-title":"Deubiquitinases in cancer: new functions and therapeutic options","volume":"31","author":"Fraile","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2025.01.046_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20140496","article-title":"DUBs, the regulation of cell identity and disease","volume":"465","author":"Heideker","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2025.01.046_bib23","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2091-9-S1-S3","article-title":"Deubiquitylating enzymes and disease","volume":"9","author":"Singhal","year":"2008","journal-title":"BMC Biochem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib24","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pro.2415","article-title":"Mechanisms for regulating deubiquitinating enzymes","volume":"23","author":"Wolberger","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.ymthe.2025.01.046_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/db16-0743","article-title":"Lack of CUL4B in Adipocytes Promotes PPAR\u03b3-Mediated Adipose Tissue Expansion and Insulin Sensitivity","volume":"66","author":"Li","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.ymthe.2025.01.046_bib26","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1038\/emm.2016.31","article-title":"F-box only protein 9 is an E3 ubiquitin ligase of PPAR\u03b3","volume":"48","author":"Lee","year":"2016","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymthe.2025.01.046_bib27","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/cdd.2013.181","article-title":"Suppression of PPAR\u03b3 through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation","volume":"21","author":"Kim","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2025.01.046_bib28","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1210\/en.2011-1725","article-title":"The ubiquitin ligase Siah2 regulates PPAR\u03b3 activity in adipocytes","volume":"153","author":"Kilroy","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ymthe.2025.01.046_bib29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s13238-013-2124-z","article-title":"Upregulation of SIRT1 by 17\u03b2-estradiol depends on ubiquitin-proteasome degradation of PPAR-\u03b3 mediated by NEDD4-1","volume":"4","author":"Han","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.ymthe.2025.01.046_bib30","doi-asserted-by":"crossref","first-page":"18504","DOI":"10.1074\/jbc.RA119.009282","article-title":"Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPAR\u03b3 for proteasomal degradation","volume":"294","author":"Dou","year":"2019","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154302","article-title":"Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression","volume":"110","author":"Noh","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.ymthe.2025.01.046_bib32","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41467-022-29846-9","article-title":"USP22 regulates lipidome accumulation by stabilizing PPAR\u03b3 in hepatocellular carcinoma","volume":"13","author":"Ning","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.046_bib33","doi-asserted-by":"crossref","first-page":"32886","DOI":"10.1074\/jbc.M113.496331","article-title":"Herpesvirus-associated ubiquitin-specific protease (HAUSP) modulates peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) stability through its deubiquitinating activity","volume":"288","author":"Lee","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib35","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1111\/cas.15509","article-title":"Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma","volume":"113","author":"Sun","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ymthe.2025.01.046_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-022-04629-z","article-title":"Hepatocyte PPAR\u03b3 contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice","volume":"80","author":"Lee","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymthe.2025.01.046_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41392-022-01209-2","article-title":"Identification of a class of potent USP25\/28 inhibitors with broad-spectrum anti-cancer activity","volume":"7","author":"Peng","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2025.01.046_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hep.30401","article-title":"Dietary Lipids Differentially Shape Nonalcoholic Steatohepatitis Progression and the Transcriptome of Kupffer Cells and Infiltrating Macrophages","volume":"70","author":"McGettigan","year":"2019","journal-title":"Hepatol. (Baltimore, Md"},{"key":"10.1016\/j.ymthe.2025.01.046_bib41","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jc.2010-2129","article-title":"Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction","volume":"96","author":"Pettinelli","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymthe.2025.01.046_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/CS20100387","article-title":"Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C","volume":"120","author":"Lima-Cabello","year":"2011","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ymthe.2025.01.046_bib43","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3389\/fendo.2019.00599","article-title":"Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver Disease","volume":"10","author":"Jia","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.ymthe.2025.01.046_bib45","doi-asserted-by":"crossref","first-page":"34268","DOI":"10.1074\/jbc.M300043200","article-title":"Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass","volume":"278","author":"Gavrilova","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib46","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jcmgh.2021.01.003","article-title":"Hepatocyte-Specific Loss of PPAR\u03b3 Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver","volume":"11","author":"Lee","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ncb1601","article-title":"The ubiquitin-specific protease USP28 is required for MYC stability","volume":"9","author":"Popov","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymthe.2025.01.046_bib48","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1172\/JCI73733","article-title":"The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer","volume":"124","author":"Diefenbacher","year":"2014","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.01.046_bib49","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911101","article-title":"Maintaining protein stability of \u0394Np63 via USP28 is required by squamous cancer cells","volume":"12","author":"Prieto-Garcia","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.01.046_bib50","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood-2011-08-375014","article-title":"GSK-3\u03b2 regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1\u03b1","volume":"119","author":"Fl\u00fcgel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.01.046_bib51","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41418-023-01173-6","article-title":"USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer","volume":"30","author":"Maier","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2025.01.046_bib52","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.molcel.2019.12.023","article-title":"Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2\/M Checkpoint through Cleavage of USP28","volume":"77","author":"M\u00fcller","year":"2020","journal-title":"Mol. Cel."},{"key":"10.1016\/j.ymthe.2025.01.046_bib53","doi-asserted-by":"crossref","first-page":"11431","DOI":"10.1074\/jbc.M116.767178","article-title":"Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel","volume":"292","author":"Li","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2025.01.046_bib54","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.7150\/thno.53412","article-title":"Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2025.01.046_bib55","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1038\/s41467-023-39412-6","article-title":"USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.01.046_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J.\u00a0Hepatol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:47:18Z","timestamp":1778816838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162500084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S152500162500084X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.046","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The deubiquitinase USP28 maintains the expression of PPAR\u03b3 and its inactivation protects mice from diet-induced MASH and hepatocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}